173 related articles for article (PubMed ID: 31697475)
21. Active control of pharmacokinetics using light-responsive polymer-drug conjugates for boron neutron capture therapy.
Tokura D; Konarita K; Suzuki M; Ogata K; Honda Y; Miura Y; Nishiyama N; Nomoto T
J Control Release; 2024 Jul; 371():445-454. PubMed ID: 38844180
[TBL] [Abstract][Full Text] [Related]
22. Hydrophobic boron compound-loaded poly(l-lactide-co-glycolide) nanoparticles for boron neutron capture therapy.
Takeuchi I; Nomura K; Makino K
Colloids Surf B Biointerfaces; 2017 Nov; 159():360-365. PubMed ID: 28806667
[TBL] [Abstract][Full Text] [Related]
23. Assessment of
Shimosegawa E; Isohashi K; Naka S; Horitsugi G; Hatazawa J
Ann Nucl Med; 2016 Dec; 30(10):749-755. PubMed ID: 27586407
[TBL] [Abstract][Full Text] [Related]
24. Boron neutron-capture therapy (BNCT) for glioblastoma multiforme (GBM) using the epithermal neutron beam at the Brookhaven National Laboratory.
Chadha M; Capala J; Coderre JA; Elowitz EH; Iwai J; Joel DD; Liu HB; Wielopolski L; Chanana AD
Int J Radiat Oncol Biol Phys; 1998 Mar; 40(4):829-34. PubMed ID: 9531367
[TBL] [Abstract][Full Text] [Related]
25. Evaluation of pharmacokinetics of 4-borono-2-(18)F-fluoro-L-phenylalanine for boron neutron capture therapy in a glioma-bearing rat model with hyperosmolar blood-brain barrier disruption.
Hsieh CH; Chen YF; Chen FD; Hwang JJ; Chen JC; Liu RS; Kai JJ; Chang CW; Wang HE
J Nucl Med; 2005 Nov; 46(11):1858-65. PubMed ID: 16269600
[TBL] [Abstract][Full Text] [Related]
26. Comparison of the pharmacokinetics between L-BPA and L-FBPA using the same administration dose and protocol: a validation study for the theranostic approach using [
Watanabe T; Hattori Y; Ohta Y; Ishimura M; Nakagawa Y; Sanada Y; Tanaka H; Fukutani S; Masunaga SI; Hiraoka M; Ono K; Suzuki M; Kirihata M
BMC Cancer; 2016 Nov; 16(1):859. PubMed ID: 27821116
[TBL] [Abstract][Full Text] [Related]
27. Translational boron neutron capture therapy (BNCT) studies for the treatment of tumors in lung.
Trivillin VA; Serrano A; Garabalino MA; Colombo LL; Pozzi EC; Hughes AM; Curotto PM; Thorp SI; Farías RO; González SJ; Bortolussi S; Altieri S; Itoiz ME; Aromando RF; Nigg DW; Schwint AE
Int J Radiat Biol; 2019 May; 95(5):646-654. PubMed ID: 30601686
[TBL] [Abstract][Full Text] [Related]
28. Applications and perspectives of boron-enriched nanocomposites in cancer therapy.
Yinghuai Z; Hosmane NS
Future Med Chem; 2013 Apr; 5(6):705-14. PubMed ID: 23617432
[TBL] [Abstract][Full Text] [Related]
29. Boron delivery for boron neutron capture therapy targeting a cancer-upregulated oligopeptide transporter.
Miyabe J; Ohgaki R; Saito K; Wei L; Quan L; Jin C; Liu X; Okuda S; Nagamori S; Ohki H; Yoshino K; Inohara H; Kanai Y
J Pharmacol Sci; 2019 Mar; 139(3):215-222. PubMed ID: 30833090
[TBL] [Abstract][Full Text] [Related]
30. Delivery of (10)boron to oral squamous cell carcinoma using boronophenylalanine and borocaptate sodium for boron neutron capture therapy.
Obayashi S; Kato I; Ono K; Masunaga S; Suzuki M; Nagata K; Sakurai Y; Yura Y
Oral Oncol; 2004 May; 40(5):474-82. PubMed ID: 15006618
[TBL] [Abstract][Full Text] [Related]
31. Assessing advantages of sequential boron neutron capture therapy (BNCT) in an oral cancer model with normalized blood vessels.
Molinari AJ; Thorp SI; Portu AM; Saint Martin G; Pozzi EC; Heber EM; Bortolussi S; Itoiz ME; Aromando RF; Monti Hughes A; Garabalino MA; Altieri S; Trivillin VA; Schwint AE
Acta Oncol; 2015 Jan; 54(1):99-106. PubMed ID: 24960584
[TBL] [Abstract][Full Text] [Related]
32. Early effect of boron neutron capture therapy mediated by boronophenylalanine (BPA-BNCT) on mast cells in premalignant tissue and tumors of the hamster cheek pouch.
Aromando RF; Trivillin VA; Heber EM; Pozzi E; Schwint AE; Itoiz ME
Oral Oncol; 2010 May; 46(5):355-9. PubMed ID: 20308008
[TBL] [Abstract][Full Text] [Related]
33. Neutron capture therapy of the 9L rat gliosarcoma using the p-boronophenylalanine-fructose complex.
Coderre JA; Button TM; Micca PL; Fisher CD; Nawrocky MM; Liu HB
Int J Radiat Oncol Biol Phys; 1994 Oct; 30(3):643-52. PubMed ID: 7928496
[TBL] [Abstract][Full Text] [Related]
34. Advancements in Tumor Targeting Strategies for Boron Neutron Capture Therapy.
Luderer MJ; de la Puente P; Azab AK
Pharm Res; 2015 Sep; 32(9):2824-36. PubMed ID: 26033767
[TBL] [Abstract][Full Text] [Related]
35. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine.
Yang W; Barth RF; Rotaru JH; Moeschberger ML; Joel DD; Nawrocky MM; Goodman JH
J Neurooncol; 1997 May; 33(1-2):59-70. PubMed ID: 9151224
[TBL] [Abstract][Full Text] [Related]
36. Amphiphilic Polycarbonates from Carborane-Installed Cyclic Carbonates as Potential Agents for Boron Neutron Capture Therapy.
Xiong H; Wei X; Zhou D; Qi Y; Xie Z; Chen X; Jing X; Huang Y
Bioconjug Chem; 2016 Sep; 27(9):2214-23. PubMed ID: 27548011
[TBL] [Abstract][Full Text] [Related]
37. Effects of boron neutron capture therapy on human oral squamous cell carcinoma in a nude mouse model.
Kamida A; Obayashi S; Kato I; Ono K; Suzuki M; Nagata K; Sakurai Y; Yura Y
Int J Radiat Biol; 2006 Jan; 82(1):21-9. PubMed ID: 16546900
[TBL] [Abstract][Full Text] [Related]
38. Application of drug delivery system to boron neutron capture therapy for cancer.
Yanagië H; Ogata A; Sugiyama H; Eriguchi M; Takamoto S; Takahashi H
Expert Opin Drug Deliv; 2008 Apr; 5(4):427-43. PubMed ID: 18426384
[TBL] [Abstract][Full Text] [Related]
39. 4-Borono-2-
Ishiwata K
Ann Nucl Med; 2019 Apr; 33(4):223-236. PubMed ID: 30820862
[TBL] [Abstract][Full Text] [Related]
40. [Possibilities of boron neutron capture therapy in the treatment of malignant brain tumors].
Kanygin VV; Kichigin AI; Gubanova NV; Taskaev SY
Vestn Rentgenol Radiol; 2015; (6):36-42. PubMed ID: 26999933
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]